Bacterioph00ages for gut health
Bacteriaph00ages 有益于肠道健康
基本信息
- 批准号:BB/W015706/1
- 负责人:
- 金额:$ 78.3万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2022
- 资助国家:英国
- 起止时间:2022 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Bacteriophages (phages), viruses that specifically target and infect bacteria, are a major component of the gut microbiome, but they are not as well-studied as their bacterial hosts. Recent high-throughput sequencing approaches have revealed tens of thousands of different phage species in the healthy gut. These phages continuously interact with each other and their bacterial hosts, but we have very limited information on how they interact with the cells of the human gut. Previous studies on individual bacteriophages raised the possibility that the gut epithelium can act as a sink for bacteriophages, while other studies showed a range of gut epithelial responses differing from phage to phage. What we currently have no information on, is how phage communities as a whole interact with the human gut epithelial environment. In this project, we will take advantage of the availability of gut microbiome studies and human biopsy-derived intestinal organoid-based cell models at our Institute to investigate phage-gut interactions with the epithelium. The gut microbiome studies currently running at the Quadram Institute Bioscience (QIB), the PEARL study (investigating the role of the gut microbiome in pregnancy and early life) and the MOTION study (investigating the role of the gut microbiome in older adults), will allow us to use microbiome sequencing information and the associated faecal samples to generate natural human gut phage communities. These communities will then be tested on biopsy-derived culture models of human gut cells, called organoids, that mimic the gut environment. More specifically, we will combine the phage communities with the human gut organoids and monitor the changes over time for both the phage communities and the human gut cells. Using high-throughput sequencing and qPCR, we will quantify the changes in phage community composition and structural protein content, and track phages across the cell monolayer. We will investigate the cellular response by looking at markers of gut barrier function. In parallel, we will develop a phage biobank of cultured isolates that can be used in the future for the biocontrol of gut-associated bacterial pathogens or for the modulation of the gut microbiome. Informed by the data on the phage-gut interactions, we will assemble cocktails of different phages that are most suited for use in the human gut, and test these on our gut organoid system. This study will increase our functional understanding of bacteriophages as part of a healthy gut microbiome. Through the identification of the phage types that are most adapted to the gut environment and the response of the gut epithelium, we will be able to form a more comprehensive picture of phage-gut interactions. In addition, the findings will allow us to make better informed decisions on the appropriateness of specific phage types for potential application as therapeutics.
噬菌体(Bacteriophage,简称BPV)是一种专门针对和感染细菌的病毒,是肠道微生物组的主要组成部分,但它们的研究不如细菌宿主。最近的高通量测序方法已经揭示了健康肠道中成千上万种不同的噬菌体种类。这些细菌不断相互作用,并与它们的细菌宿主相互作用,但我们对它们如何与人类肠道细胞相互作用的信息非常有限。先前对单个噬菌体的研究提出了肠道上皮可以作为噬菌体的水槽的可能性,而其他研究显示了一系列噬菌体与噬菌体不同的肠道上皮反应。我们目前没有关于噬菌体群落作为一个整体如何与人类肠道上皮环境相互作用的信息。在这个项目中,我们将利用我们研究所的肠道微生物组研究和人类活检衍生的肠道类器官细胞模型的可用性来研究噬菌体-肠道与上皮的相互作用。目前在Quadram Institute Bioscience(QIB)进行的肠道微生物组研究,PEARL研究(调查肠道微生物组在妊娠和早期生活中的作用)和MOTION研究(调查肠道微生物组在老年人中的作用),将使我们能够使用微生物组测序信息和相关的粪便样本来生成天然的人类肠道噬菌体群落。然后,这些社区将在模拟肠道环境的人类肠道细胞(称为类器官)的活检衍生培养模型上进行测试。更具体地说,我们将联合收割机结合噬菌体群落与人类肠道类器官,并监测噬菌体群落和人类肠道细胞随时间的变化。使用高通量测序和qPCR,我们将量化噬菌体群落组成和结构蛋白含量的变化,并跟踪整个细胞单层的噬菌体。我们将通过观察肠道屏障功能的标志物来研究细胞反应。同时,我们将开发一个培养分离株的噬菌体生物库,将来可用于肠道相关细菌病原体的生物防治或肠道微生物组的调节。根据噬菌体-肠道相互作用的数据,我们将组装最适合在人类肠道中使用的不同微生物的鸡尾酒,并在我们的肠道类器官系统上测试这些。这项研究将增加我们对噬菌体作为健康肠道微生物组一部分的功能性理解。通过鉴定最适应肠道环境的噬菌体类型和肠道上皮的反应,我们将能够形成更全面的噬菌体-肠道相互作用的图景。此外,这些发现将使我们能够对特定噬菌体类型作为治疗剂的潜在应用的适当性做出更明智的决定。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bacteriophage Taxonomy: A Continually Evolving Discipline.
噬菌体分类学:一门不断发展的学科。
- DOI:10.1007/978-1-0716-3523-0_3
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Turner D
- 通讯作者:Turner D
Nanopore and Illumina Sequencing Reveal Different Viral Populations from Human Gut Samples
Nanopore 和 Illumina 测序揭示了人类肠道样本中的不同病毒种群
- DOI:10.1101/2023.11.24.568560
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Cook R
- 通讯作者:Cook R
Changes to virus taxonomy and the ICTV Statutes ratified by the International Committee on Taxonomy of Viruses (2023).
国际病毒分类委员会批准的病毒分类和 ICTV 章程的变更(2023 年)。
- DOI:10.1007/s00705-023-05797-4
- 发表时间:2023
- 期刊:
- 影响因子:2.7
- 作者:Zerbini FM
- 通讯作者:Zerbini FM
Predicting stop codon reassignment improves functional annotation of bacteriophages
预测终止密码子重新分配可改善噬菌体的功能注释
- DOI:10.1101/2023.12.19.572299
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Cook R
- 通讯作者:Cook R
Author Correction: Guidelines for public database submission of uncultivated virus genome sequences for taxonomic classification.
作者更正:公共数据库提交未培养病毒基因组序列用于分类学分类的指南。
- DOI:10.1038/s41587-023-01952-z
- 发表时间:2023
- 期刊:
- 影响因子:46.9
- 作者:Adriaenssens EM
- 通讯作者:Adriaenssens EM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Evelien Adriaenssens其他文献
Evelien Adriaenssens的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Evelien Adriaenssens', 18)}}的其他基金
Phage treatment and wetland technology as intervention strategy to prevent dissemination of antibiotic resistance in surface waters
噬菌体处理和湿地技术作为防止地表水中抗生素耐药性传播的干预策略
- 批准号:
MR/W031205/1 - 财政年份:2022
- 资助金额:
$ 78.3万 - 项目类别:
Research Grant
Canada Partnering Award: A one health approach to understanding and using bacteriophages in the control of enteric pathogens
加拿大合作奖:了解和使用噬菌体控制肠道病原体的单一健康方法
- 批准号:
BB/V018086/1 - 财政年份:2021
- 资助金额:
$ 78.3万 - 项目类别:
Research Grant
相似国自然基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
- 批准号:82371251
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
- 批准号:82372306
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
- 批准号:81801389
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
酰基化脑肠肽抑制脑缺血引起神经元凋亡的分子机制
- 批准号:30370557
- 批准年份:2003
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 78.3万 - 项目类别:
How food speaks to you: A new brain-gut axis for lifelong health.
食物如何与你对话:终身健康的新脑肠轴。
- 批准号:
BB/X015106/1 - 财政年份:2024
- 资助金额:
$ 78.3万 - 项目类别:
Research Grant
BACMETH: Bacterial methylation of the human gut microbiome in response to diet for improvement of cardiometabolic health
BACMETH:人类肠道微生物组的细菌甲基化响应饮食以改善心脏代谢健康
- 批准号:
EP/Y023765/1 - 财政年份:2024
- 资助金额:
$ 78.3万 - 项目类别:
Research Grant
Synthetically engineered microalgae for improved gut function and human health
合成工程微藻可改善肠道功能和人类健康
- 批准号:
BB/Y00857X/1 - 财政年份:2024
- 资助金额:
$ 78.3万 - 项目类别:
Research Grant
Early life determinants of childhood adiposity, appetite regulation, and obesogenic dietary behaviours.
儿童肥胖、食欲调节和肥胖饮食行为的早期决定因素。
- 批准号:
478850 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
Operating Grants
Non-nutritive sweetener consumption during pregnancy and child body mass index: can postnatal fibre consumption mitigate potential risks?
怀孕期间的非营养性甜味剂消费和儿童体重指数:产后纤维消费可以减轻潜在风险吗?
- 批准号:
488069 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
Operating Grants
Characterization of metabolic contribution from the microbiota in the gut-brain axis
肠脑轴微生物群代谢贡献的表征
- 批准号:
486908 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
Miscellaneous Programs
The Gut as a Target to Improve Outcomes in Sepsis
肠道作为改善脓毒症预后的目标
- 批准号:
10552403 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
Precision Nutrition for Gut Health: Development of a novel seaweed-containing, gut microbiota targeted nutraceutical
肠道健康的精准营养:开发一种新型的含海藻、针对肠道微生物群的营养保健品
- 批准号:
2886525 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别:
Studentship
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 78.3万 - 项目类别: